Elevation in serum troponin I predicts the benefit of tirofiban

Journal of Thrombosis and Thrombolysis

Volumn 11, Issue 3, 2001, Pages 211-215

  Januzzi, J L ^a   Chae, C U ^a   Sabatine, M S ^a   Jang, I K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Acute coronary syndromes; Glycoprotein IIb IIIa inhibitor; Troponins

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOCHEMICAL MARKER; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN; TROPONIN I;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE MARKER; FEMALE; HEART INFARCTION; HEART INJURY; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ST SEGMENT DEPRESSION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TROPONIN I; TYROSINE;

EID: 0035161957     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011956703031     Document Type: Article

References (19)

1. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
2. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
3. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy
4. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
5. Angiographic findings in patients with refractory unstable angina according to troponin T status
6. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators
7. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death
8. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death: Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion
9. Coronary microembolization
10. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators
11. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofibon. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management
12. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group
13. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making
14. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
15. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators
16. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: The PARAGON-B troponin T substudy
17. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes
18. Association of intracoronary thrombus and troponin I levels in patients with unstable angina or non-Q-wave myocardial infarction in PRISM-PLUS